Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform

Today is 2022-05-21

简体中文|English

Trial search

Filter Options
Public title		Scientific title		Subject ID
Registration Status		Registration number		Secondary ID
Applicant		Study leader		Year
Primary sponsor		Secondary sponsor		Source(s) of funding
Target disease		Target disease code		Study type
Study phase		Study design		Study execute time	From To
Recruiting status		Gender		Sign the informed consent
Countries of recruitment and research settings	Nation(Area)：Province：City： Institution：Level of the institution：
Intervention		Intervention code		Approved by ethic committee
Calculated Results after the Study Completed public access		Statistical results after completion of the test file upload
	More Options

15178 trials have been registered

Historical versions	Registration number	Public title	Type	Registration time
Historical Versions	ChiCTR2200060160	Association of postoperative delirium and regional cerebral oxygen saturation and preoperative frailty elderly patients under general anesthesia Enze Hospital, Taizhou Enze Medical Center (Group)	Observational	2022/05/20
Historical Versions	ChiCTR2200060149	The safety and effectiveness of primidone in the treatment of amyotrophic lateral sclerosis：A single-center, retrospective cohort study. The First Hospital of Yichang	Observational	2022/05/20
Historical Versions	ChiCTR2200060148	Investigation, evidence-based evaluation and risk prevention of off-label drug use in psychiatry The Second Affiliated Hospital of Xinxiang Medical College	Observational	2022/05/20
Historical Versions	ChiCTR2200060145	Ubenimex capsules（Bestatin） and chemotherapy for the patients with metastatic breast cancer（MBC）: A real-world study Zhejiang Cancer Hospital	Observational	2022/05/20
Historical Versions	ChiCTR2200060142	Randomized, double-blind, positive drug parallel control, multi-center Chinese medicine variety protection clinical trial on the efficacy and safety of Baihe Gujin tablet in the treatment of chronic pharyngitis (lung-kidney yin deficiency syndrome) Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University	Observational	2022/05/20
Historical Versions	ChiCTR2200060141	Randomized, double-blind, positive drug parallel control, multi-center Chinese medicine variety protection clinical trial on the efficacy and safety of Baihe Gujin tablet in the treatment of post-cold cough (lung-kidney yin deficiency syndrome). Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University	Observational	2022/05/20
Historical Versions	ChiCTR2200060136	Nituzumab plus terriprizumab combined with GP versus nituzumab combined with GP in patients with high-risk locally advanced nasopharyngeal carcinoma: a multicenter, randomized controlled, open clinical study Sun Yat-sen University Cancer Center	Observational	2022/05/20
Historical Versions	ChiCTR2200060133	Trajectory of immunosuppression and its association with prognosis in children with severe sepsis Children's Hospital of Chongqing Medical University	Observational	2022/05/19
Historical Versions	ChiCTR2200060130	The clinical trial of opioid-sparing anesthesia undergoing major laparoscopic abdominal surgery Guangdong Provincial Hospital of Chinese Medicine	Observational	2022/05/19
Historical Versions	ChiCTR2200060128	High-risk factors for benign epilepsy in children with centrotemporal spikes to evolve into variants, and related research on constructing and validating their prediction models Children’s Hospital of Chongqing Medical University	Observational	2022/05/19

First 1 2 3 4 5 6 7 8 9 10 Next Last No.1\Total 1518

临床试验公共管理平台 Clinical Trial Management Public Platform

中国注册临床试验伦理审查委员会 chinese ethics committee of registering clinical trials

医学期刊出版与编辑伦理网 Medical Journal Publication and Edite Ethics Network

欢迎访问WHO国际临床试验注册平台

Clinical Trials Hong Kong

Ottawa Statement on Trial Registration

北京针灸临床试验注册中心

Home|
About ChiCTR|
Trial Search|
Document|
Reg guide|
Question